American Medical Journal

The FDA has launched a dedicated accelerator for Alzheimer’s prevention. The initiative will look at new trial designs, stage-appropriate endpoints and biomarkers to help show whether therapies can delay cognitive decline. Learn more: hubs.la/Q04DcFq90

From CAR-T therapies to AI, innovation takes center stage at @ACRheum's #ACR26! AMJ Rheumatology will be reporting from Orlando, bringing you the research and clinical insights that matter. Join now for more coverage: hubs.ly/Q04DvLwR0 #Rheumatology #MedicalCongress

Nearly 374,000 aortic valve replacements reveal a clear gap in infection rates. Data presented at IDWeek 2026 linked TAVR with a 51% lower endocarditis rate than surgery. Once infection set in, 12-month mortality no longer differed significantly. hubs.la/Q04DcFcY0

Radiation worries may be keeping high-risk Asian American women from annual lung scans. Data found 96.4% would recommend low-dose CT to others, but few intended to return each year. Education and patient navigators may help close the gap. hubs.la/Q04DcBXz0

Can a chemotherapy-free approach delay progression in metastatic sensitive prostate cancer? Phase III data show adding an androgen receptor inhibitor to ADT slowed radiographic progression, with fewer discontinuations for adverse events than placebo. hubs.la/Q04Dczv70

A positive patch test alone may not be enough to diagnose systemic contact dermatitis. The authors advise combining it with a structured exposure history, including when flares occur. Find out more: hubs.la/Q04CVK4R0

Why do stressful moments leave stronger memories? New neuroimaging work suggests cortisol prioritizes emotionally salient experiences, which could inform future research into conditions such as PTSD. See the findings: hubs.la/Q04CVKfg0

Muscle power starts to decline decades earlier than many people might expect. A 47-year study found that muscle power peaked at age 19 in women and 27 in men. After that, it gradually declined. hubs.la/Q04CVJR00

RSV after a lung transplant can have lasting effects on breathing. In a study of 61 patients, lung function declined after RSV infection, with median FEV1 falling from 2.01 L to 1.69 L. Read the analysis: hubs.la/Q04CVJfJ0

New evidence is challenging infectious disease management. At @IDWeekMtg's #IDWeek2026, research explored long-acting HIV therapy, shorter TB treatment, and childhood hepatitis B exposure. Join AMJ for free for more insights: hubs.la/Q04CVFWL0

Healthcare worker burnout may vary significantly across career stages. A cross-sectional study found burnout in 66.91% of hospital professionals, with the highest prevalence among those with 16–20 years of service. Read more: hubs.la/Q04CC36m0

Starting HPV vaccination at ages 9–10 was linked to higher completion rates by age 13. IDWeek 2026 findings showed 61.6% completed the series, compared with 45.1% of those starting at ages 11–12. Read more: hubs.la/Q04Cm6_L0

Grape skin extract shows a potential signal for dry eye - but it’s far from proven. Gains appeared on tear production and fatigue, yet validated indices like the OSDI showed no significant difference. Full story on AMJ: hubs.ly/Q04C33Gl0

Could immersive VR aid recovery after acute respiratory distress syndrome? Patients using it showed greater cognitive and quality-of-life gains - but they also received more structured rehab, muddying the picture. Learn more: hubs.ly/Q04C33md0

More young adults are surviving stroke - but also living longer with its consequences. As incidence climbs and acute survival improves, a growing population faces long-term disability and recurrence risk. Explore the findings: hubs.ly/Q04C331h0

What is the true economic cost of antimicrobial resistance? Read more: hubs.la/Q04C8VW_0 #AntimicrobialResistance #AMR #InfectiousDiseases

West Nile virus has reached 1,328 cases across 45 US states - and over 75% are the severe, neuroinvasive form. Surveillance data points to a sharp seasonal escalation, with milder cases likely underreported. Read more: hubs.la/Q04C32fd0

How much cancer is preventable? A global analysis points to infections behind 12% of all cases. Much of that burden - from HPV to hepatitis B - is addressable through vaccination, screening and antiviral therapy. Explore the findings: hubs.ly/Q04C31Gz0

Could long-acting injectable HIV treatment hold up outside clinical trials? Read more: hubs.la/Q04C2djD0 #HIV #InfectiousDiseases #IDWeek2026

In infectious diseases, the next challenge is never far away. Neither is the science to tackle it. At #IDWeek2026, new evidence on emerging pathogens, HIV, vaccines, and infection prevention will take center stage. Join AMJ for more: hubs.la/Q04z_J0x0